메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
차승현 (대구가톨릭대학교 약학대학) 임지현 (대구가톨릭대학교 약학대학) 송윤경 (대구가톨릭대학교)
저널정보
한국임상약학회 한국임상약학회지 한국임상약학회지 제32권 제4호
발행연도
2022.12
수록면
352 - 361 (10page)
DOI
https://doi.org/10.24304/kjcp.2022.32.4.352

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objective: This study aimed to analyze the important medical adverse events (IMEs) of cyclosporine and tacrolimus using thereports in US FDA adverse event reporting system (FAERS) and to detect related signals. Methods: The FAERS database was usedto analyze the IMEs reported for cyclosporine or tacrolimus during 2017-2021. Reporting odds ratio (ROR) and informationcomponent were used to analyze signals for adverse events of both drugs. It was investigated whether the detected signals werepresent on drug labels in Korea and the United States. Results: Among the total 24,688 reports, the reports on tacrolimus accounted75.8%. Mean age of the patients was 47.9 years old and median number of adverse events was 2.0 per report. The number of patientshospitalized for adverse events was 7,979 (25.3%). Among the adverse reactions reported on the cyclosporine and tacrolimus, 576and 1,363 events were detected as signals for cyclosporine and tacrolimus, respectively, and of these, IMEs accounted for 44.8 and59.2%, respectively. The IMEs related with infections/infestations, renal/urinary disorders, and blood and lymphatic systemdisorders were reported frequently for both drugs. The most frequently detected IMEs were renal impairment for cyclosporine andacute kidney injury for tacrolimus. Among the top 3 IMEs for each reported SOC for cyclosporine and tacrolimus, 9 and 2unexpected adverse events were identified, respectively. Conclusion: This study identified the IMEs and signals of cyclosporine andtacrolimus, and detected unidentified adverse events in a drug information database.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0